[
  {
    "ts": null,
    "headline": "Strength in Network Software Drives Roper: Can the Momentum Sustain?",
    "summary": "ROP lifts its 2025 outlook as the Network Software and Application Software segments gain from GenAI, cross-sell and strong demand.",
    "url": "https://finnhub.io/api/news?id=ddfa862a280a2caf740a2b023bb7d9cb935d0844f275a3f0a8f13b5aa183421c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758550680,
      "headline": "Strength in Network Software Drives Roper: Can the Momentum Sustain?",
      "id": 136851396,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "A",
      "source": "Yahoo",
      "summary": "ROP lifts its 2025 outlook as the Network Software and Application Software segments gain from GenAI, cross-sell and strong demand.",
      "url": "https://finnhub.io/api/news?id=ddfa862a280a2caf740a2b023bb7d9cb935d0844f275a3f0a8f13b5aa183421c"
    }
  },
  {
    "ts": null,
    "headline": "Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine",
    "summary": "Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, and Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced a nonexclusive collaboration to develop AI-based companion diagnostic solutions. The collaboration will leverage Lunit's AI technology and Agilent's expertise in tissue-based companion diagnostics to create advanced solutions that meet the demand of novel and complex biomarker",
    "url": "https://finnhub.io/api/news?id=3181064081ab6e4f2a6f104e8f056977db7f07312cc1873adf37a656e8ba23c5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758546000,
      "headline": "Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine",
      "id": 136851581,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "A",
      "source": "Yahoo",
      "summary": "Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, and Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, today announced a nonexclusive collaboration to develop AI-based companion diagnostic solutions. The collaboration will leverage Lunit's AI technology and Agilent's expertise in tissue-based companion diagnostics to create advanced solutions that meet the demand of novel and complex biomarker",
      "url": "https://finnhub.io/api/news?id=3181064081ab6e4f2a6f104e8f056977db7f07312cc1873adf37a656e8ba23c5"
    }
  }
]